FAPI-4 manufacturers
- FAPI-4
-
- $0.00 / 10mg
-
2024-04-02
- CAS:2374782-02-0
- Min. Order: 10mg
- Purity: >95.00%
- Supply Ability: 10mg
|
Product Name: | FAPI-4 | Synonyms: | FAPI-4;187366;(S)-2,2',2''-(10-(2-(4-(3-((4-((2-(2-cyano-4,4-difluoropyrrolidin-1-yl)-2-oxoethyl)carbamoyl)quinolin-6-yl)oxy)propyl)piperazin-1-yl)-2-oxoethyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triyl)triacetic acid;FAPI04;(S)-2,2’,2’’-[10-[2-[4-[3-[[4-[[2-(2-Cyano-4,4-difluoro-1-pyrrolidinyl)-2-oxoethyl]carbamoyl]-6-quinolyl]oxy]propyl]-1-piperazinyl]-2-oxoethyl]-1,4,7,10-tetraazacyclododecane-1,4,7-triyl]triacetic Acid;FAPI;G-1002;FAPI-4 Chemical Structure | CAS: | 2374782-02-0 | MF: | C40H54F2N10O10 | MW: | 872.93 | EINECS: | | Product Categories: | | Mol File: | 2374782-02-0.mol | |
| FAPI-4 Chemical Properties |
Boiling point | 1144.1±65.0 °C(Predicted) | density | 1.46±0.1 g/cm3(Predicted) | storage temp. | Store at -20°C | solubility | DMSO: 100 mg/mL (114.56 mM) | pka | 1.83±0.10(Predicted) | form | Solid | color | White to off-white |
| FAPI-4 Usage And Synthesis |
Uses | FAPI-4 is a substituted pyrrolidinyloxoethyl quinolinecarboxamides and one type of theranostic ligand for fibroblast activation protein (FAP). FAPI-4 is a FAP inhibitor (FAPI) and has been studied for its pharmaceutical properties in the diagnose or treatment of diseases driven by the overexpression of FAPs. |
| FAPI-4 Preparation Products And Raw materials |
|